Akèy › Kasinom Selil Transizyonèl (Urotelyal)
Etid klinik pou Kasinom Selil Transizyonèl (Urotelyal) ap rekrite nan Etazini
73 etid pou Kasinom Selil Transizyonèl (Urotelyal) ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY23 etid
- Nashville, TN22 etid
- Houston, TX19 etid
- Dallas, TX18 etid
- Edison, NJ18 etid
- Los Angeles, CA17 etid
- Queens, NY15 etid
- Chicago, IL14 etid
- Arlington, VA12 etid
- Boston, MA11 etid
- San Antonio, TX11 etid
- Austin, TX10 etid
- Orange, CA10 etid
- Baldwin Park, CA9 etid
- Philadelphia, PA9 etid
- Seattle, WA9 etid
- Washington, DC9 etid
- Columbus, OH9 etid
- Durham, NC8 etid
- Jacksonville, FL8 etid
- Atlanta, GA8 etid
- Irvine, CA8 etid
- Cleveland, OH8 etid
- Staten Island, NY7 etid
- Greenburgh, NY7 etid
- New Rochelle, NY7 etid
- Orlando, FL7 etid
- Portland, OR7 etid
- San Francisco, CA7 etid
- Omaha, NE7 etid
- East Norwalk, CT6 etid
- Santa Monica, CA6 etid
- Detroit, MI6 etid
- Ann Arbor, MI6 etid
- Phoenix, AZ6 etid
- New Haven, CT6 etid
- Denver, CO6 etid
- St. Louis, MO6 etid
- Charlotte, NC6 etid
- Oklahoma City, OK6 etid
Pa eta
- Alabama4 etid
- Arizona10 etid
- Arkansas5 etid
- Colorado10 etid
- Connecticut7 etid
- Distrik Columbia7 etid
- Florid22 etid
- Georgia11 etid
- Idaho4 etid
- Illinois21 etid
- Indiana7 etid
- Iowa7 etid
- Kalifòni33 etid
- Kentucky5 etid
- Lwizyàn4 etid
- Maryland8 etid
- Massachusetts15 etid
- Michigan15 etid
- Minnesota7 etid
- Missouri9 etid
- Montana3 etid
- Nebraska7 etid
- Nevada3 etid
- New Jersey21 etid
- New York30 etid
- North Carolina15 etid
- Ohio17 etid
- Oklahoma8 etid
- Oregon8 etid
- Pennsylvania15 etid
- South Carolina8 etid
- Tennessee24 etid
- Texas39 etid
- Utah6 etid
- Virginia21 etid
- Washington13 etid
- Wisconsin9 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07285044A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06524544Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07566156Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05874921DBC-664 in Adult Patients With Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07705035Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07421700A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07277413A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT05562830Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06047379A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07218380Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT06439836Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT05239624Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07043972A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07532902GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT04977453A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT07815665Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06293898A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06040762A Study of GEN1106 in Participants With Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07416123Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy
Ap rekriteFaz 2
Laj 18 a 99 · Fanm · Mizajou Sep 9, 2026 · NCT06184516A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07090499A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06774131A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07287995Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT06582017Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.